Mico BioMed Co. Ltd. (KQ:214610) — Stock Price
Mico BioMed Co. Ltd. (KQ:214610) is currently trading at ₩2290.00 KRW, down 2.35% today. Over the past 52 weeks, shares have ranged between ₩2255.00 and ₩5670.00. This page tracks Mico BioMed Co. Ltd.'s live share price on the KQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see 214610 stock market capitalisation.
Mico BioMed Co. Ltd. (214610) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Mico BioMed Co. Ltd.'s daily closing share price and trading volume on the KQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
Mico BioMed Co. Ltd. Income Statement — Revenue, Profit & Earnings by Year
Mico BioMed Co. Ltd.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | ₩4.64 Billion | ₩5.37 Billion | ₩16.11 Billion | ₩30.30 Billion | ₩45.67 Billion |
| Cost of Revenue | ₩10.66 Billion | ₩12.23 Billion | ₩16.51 Billion | ₩15.52 Billion | ₩24.75 Billion |
| Gross Profit | ₩-6.02 Billion | ₩-6.86 Billion | ₩-403.46 Million | ₩14.79 Billion | ₩20.92 Billion |
| Research & Development | ₩3.18 Billion | ₩4.04 Billion | ₩7.45 Billion | ₩7.83 Billion | ₩6.15 Billion |
| SG&A | ₩9.17 Billion | ₩7.55 Billion | ₩16.99 Billion | ₩16.98 Billion | ₩10.62 Billion |
| Total Operating Expenses | ₩23.87 Billion | ₩24.68 Billion | ₩16.51 Billion | ₩41.15 Billion | ₩42.16 Billion |
| Operating Income | ₩-20.65 Billion | ₩-20.36 Billion | ₩-26.98 Billion | ₩-10.90 Billion | ₩3.43 Billion |
| EBITDA | — | — | — | — | — |
| EBIT | — | — | ₩-25.92 Billion | ₩-10.86 Billion | ₩3.47 Billion |
| Interest Expense | ₩1.37 Billion | ₩3.18 Billion | ₩2.42 Billion | ₩574.75 Million | ₩694.21 Million |
| Income Before Tax | ₩-29.34 Billion | ₩-25.81 Billion | ₩-38.93 Billion | ₩-10.60 Billion | ₩-5.79 Billion |
| Income Tax Expense | — | — | — | ₩-12.97 Million | ₩-12.97 Million |
| Net Income | ₩-29.93 Billion | ₩-25.77 Billion | ₩-38.89 Billion | ₩-10.58 Billion | ₩-5.78 Billion |
Mico BioMed Co. Ltd. Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Mico BioMed Co. Ltd.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | ₩54.47 Billion | ₩61.32 Billion | ₩57.51 Billion | ₩88.68 Billion | ₩70.96 Billion |
| Total Current Assets | ₩26.71 Billion | ₩47.39 Billion | ₩36.53 Billion | ₩69.68 Billion | ₩57.31 Billion |
| Cash & Equivalents | ₩13.67 Billion | ₩9.35 Billion | ₩5.68 Billion | ₩23.81 Billion | ₩20.85 Billion |
| Short-term Investments | ₩100.00 Million | ₩13.28 Billion | ₩8.60 Billion | ₩13.06 Billion | ₩3.28 Billion |
| Net Receivables | ₩984.30 Million | ₩2.12 Billion | ₩1.68 Billion | ₩11.07 Billion | ₩10.75 Billion |
| Inventory | ₩6.97 Billion | ₩11.25 Billion | ₩17.68 Billion | ₩18.75 Billion | ₩19.52 Billion |
| Property, Plant & Equipment | ₩20.24 Billion | ₩5.61 Billion | ₩10.40 Billion | ₩16.06 Billion | ₩11.67 Billion |
| Goodwill | ₩6.50 Billion | ₩5.25 Billion | ₩28.77 Million | ₩0.00 | ₩0.00 |
| Total Liabilities | ₩28.58 Billion | ₩24.99 Billion | ₩39.82 Billion | ₩36.42 Billion | ₩15.00 Billion |
| Total Current Liabilities | ₩13.95 Billion | ₩17.54 Billion | ₩27.43 Billion | ₩11.72 Billion | ₩8.87 Billion |
| Long-term Debt | ₩9.72 Billion | ₩2.58 Billion | ₩3.38 Billion | ₩7.97 Billion | ₩65.72 Million |
| Net Debt | ₩4.51 Billion | ₩1.08 Billion | ₩14.24 Billion | — | — |
| Total Stockholder Equity | ₩25.89 Billion | ₩36.98 Billion | ₩17.69 Billion | ₩52.26 Billion | ₩55.96 Billion |
| Retained Earnings | ₩-162.69 Billion | ₩-131.73 Billion | ₩-105.86 Billion | ₩-68.23 Billion | ₩-57.04 Billion |
Mico BioMed Co. Ltd. Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Mico BioMed Co. Ltd. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₩-10.70 Billion | ₩-11.36 Billion | ₩-14.01 Billion | ₩-8.60 Billion | ₩-18.68 Billion |
| Capital Expenditures | ₩986.79 Million | ₩681.29 Million | ₩1.62 Billion | ₩2.84 Billion | ₩5.76 Billion |
| Free Cash Flow | ₩-11.68 Billion | ₩-12.04 Billion | ₩-15.67 Billion | ₩-11.73 Billion | ₩-24.70 Billion |
| Investing Cash Flow | ₩6.11 Billion | ₩-8.56 Billion | ₩-12.53 Billion | ₩-12.60 Billion | ₩-9.73 Billion |
| Financing Cash Flow | ₩8.89 Billion | ₩23.59 Billion | ₩8.33 Billion | ₩23.73 Billion | ₩39.79 Billion |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | ₩290.87 Million | — | — | — | ₩37.00K |
| Depreciation | ₩1.81 Billion | ₩1.96 Billion | ₩2.48 Billion | ₩2.44 Billion | ₩1.78 Billion |
| Change in Cash | ₩4.32 Billion | ₩3.68 Billion | ₩-18.13 Billion | ₩2.96 Billion | ₩11.25 Billion |
Mico BioMed Co. Ltd. Earnings History — EPS Actual vs. Analyst Estimates
Track Mico BioMed Co. Ltd.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 13, 2026 | — | — | — |
| Feb 25, 2026 | — | — | — |
| Nov 12, 2025 | -803.27 | — | — |
| Aug 12, 2025 | -807.00 | — | — |
| May 15, 2025 | -520.23 | — | — |
| Feb 26, 2025 | — | — | — |
| Nov 12, 2024 | -140.84 | — | — |
| Aug 14, 2024 | -166.04 | — | — |